Osseous myxochondroid sarcoma

A detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone

Elizabeth G. Demicco, Wei Lien Wang, John E. Madewell, Dali Huang, Marilyn M. Bui, Julia A. Bridge, Jeanne M. Meis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Extraskeletal myxoid chondrosarcoma (EMC) is a rare mesenchymal neoplasm with a characteristic translocation usually involving NR4A3 and EWSR1. EMC has rarely been reported in the bone and may be confused with conventional chondrosarcoma with myxoid features or various small round cell sarcomas. We present 5 cases of molecularly confirmed EMC arising primarily in the bone. Patients included 4 men and 1 woman, aged 38 to 77 years (median 54 y). Tumors arose in the ilium (2 cases), manubrium, rib, and humerus. Four tumors extensively infiltrated and destroyed preexisting bone with cortical breakthrough and associated soft tissue extension; 1 case demonstrated only focal cortical breakthrough. Microscopically, 2 cases had small round cell features; 1 of these was hypercellular, whereas the other was hypocellular with abundant myxochondroid matrix. Three cases were composed of eosinophilic spindled cells with variable fascicular to corded or wreath-like growth patterns. Fluorescence in situ hybridization was positive for both EWSR1 and NR4A3 translocation in 3 cases; rearrangement for EWSR1 or NR4A3, but not both, was seen in 2 tumors. After definitive therapy, 1 patient experienced multiple local recurrences at 36 months and died of disease at 61 months. Two patients developed lung metastases at 26 and 74 months and are alive with disease at 44 and 74 months, respectively. Two patients are disease free at 5 and 24 months. EMC of the bone is a diagnostic dilemma and requires molecular confirmation. We propose to classify tumors with the appropriate phenotype and molecularly confirmed NR4A3/EWSR1 rearrangements as myxochondroid sarcoma, either osseous or extraskeletal variants.

Original languageEnglish (US)
Pages (from-to)752-762
Number of pages11
JournalAmerican Journal of Surgical Pathology
Volume37
Issue number5
DOIs
StatePublished - May 1 2013

Fingerprint

Sarcoma
Bone and Bones
Neoplasms
Small Cell Sarcoma
Manubrium
Ilium
Chondrosarcoma
Humerus
Ribs
Fluorescence In Situ Hybridization
Extraskeletal Myxoid Chondrosarcoma
Neoplasm Metastasis
Phenotype
Recurrence
Lung
Growth
Therapeutics

Keywords

  • EWSR1
  • NR4A3
  • bone
  • extraskeletal myxoid chondrosarcoma
  • imaging
  • molecular diagnostics
  • myxochondroid sarcoma

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Osseous myxochondroid sarcoma : A detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone. / Demicco, Elizabeth G.; Wang, Wei Lien; Madewell, John E.; Huang, Dali; Bui, Marilyn M.; Bridge, Julia A.; Meis, Jeanne M.

In: American Journal of Surgical Pathology, Vol. 37, No. 5, 01.05.2013, p. 752-762.

Research output: Contribution to journalArticle

Demicco, Elizabeth G. ; Wang, Wei Lien ; Madewell, John E. ; Huang, Dali ; Bui, Marilyn M. ; Bridge, Julia A. ; Meis, Jeanne M. / Osseous myxochondroid sarcoma : A detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone. In: American Journal of Surgical Pathology. 2013 ; Vol. 37, No. 5. pp. 752-762.
@article{d71c8adc0d3e48138e1b6729e7ac4e18,
title = "Osseous myxochondroid sarcoma: A detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone",
abstract = "Extraskeletal myxoid chondrosarcoma (EMC) is a rare mesenchymal neoplasm with a characteristic translocation usually involving NR4A3 and EWSR1. EMC has rarely been reported in the bone and may be confused with conventional chondrosarcoma with myxoid features or various small round cell sarcomas. We present 5 cases of molecularly confirmed EMC arising primarily in the bone. Patients included 4 men and 1 woman, aged 38 to 77 years (median 54 y). Tumors arose in the ilium (2 cases), manubrium, rib, and humerus. Four tumors extensively infiltrated and destroyed preexisting bone with cortical breakthrough and associated soft tissue extension; 1 case demonstrated only focal cortical breakthrough. Microscopically, 2 cases had small round cell features; 1 of these was hypercellular, whereas the other was hypocellular with abundant myxochondroid matrix. Three cases were composed of eosinophilic spindled cells with variable fascicular to corded or wreath-like growth patterns. Fluorescence in situ hybridization was positive for both EWSR1 and NR4A3 translocation in 3 cases; rearrangement for EWSR1 or NR4A3, but not both, was seen in 2 tumors. After definitive therapy, 1 patient experienced multiple local recurrences at 36 months and died of disease at 61 months. Two patients developed lung metastases at 26 and 74 months and are alive with disease at 44 and 74 months, respectively. Two patients are disease free at 5 and 24 months. EMC of the bone is a diagnostic dilemma and requires molecular confirmation. We propose to classify tumors with the appropriate phenotype and molecularly confirmed NR4A3/EWSR1 rearrangements as myxochondroid sarcoma, either osseous or extraskeletal variants.",
keywords = "EWSR1, NR4A3, bone, extraskeletal myxoid chondrosarcoma, imaging, molecular diagnostics, myxochondroid sarcoma",
author = "Demicco, {Elizabeth G.} and Wang, {Wei Lien} and Madewell, {John E.} and Dali Huang and Bui, {Marilyn M.} and Bridge, {Julia A.} and Meis, {Jeanne M.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1097/PAS.0b013e3182796e46",
language = "English (US)",
volume = "37",
pages = "752--762",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Osseous myxochondroid sarcoma

T2 - A detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone

AU - Demicco, Elizabeth G.

AU - Wang, Wei Lien

AU - Madewell, John E.

AU - Huang, Dali

AU - Bui, Marilyn M.

AU - Bridge, Julia A.

AU - Meis, Jeanne M.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Extraskeletal myxoid chondrosarcoma (EMC) is a rare mesenchymal neoplasm with a characteristic translocation usually involving NR4A3 and EWSR1. EMC has rarely been reported in the bone and may be confused with conventional chondrosarcoma with myxoid features or various small round cell sarcomas. We present 5 cases of molecularly confirmed EMC arising primarily in the bone. Patients included 4 men and 1 woman, aged 38 to 77 years (median 54 y). Tumors arose in the ilium (2 cases), manubrium, rib, and humerus. Four tumors extensively infiltrated and destroyed preexisting bone with cortical breakthrough and associated soft tissue extension; 1 case demonstrated only focal cortical breakthrough. Microscopically, 2 cases had small round cell features; 1 of these was hypercellular, whereas the other was hypocellular with abundant myxochondroid matrix. Three cases were composed of eosinophilic spindled cells with variable fascicular to corded or wreath-like growth patterns. Fluorescence in situ hybridization was positive for both EWSR1 and NR4A3 translocation in 3 cases; rearrangement for EWSR1 or NR4A3, but not both, was seen in 2 tumors. After definitive therapy, 1 patient experienced multiple local recurrences at 36 months and died of disease at 61 months. Two patients developed lung metastases at 26 and 74 months and are alive with disease at 44 and 74 months, respectively. Two patients are disease free at 5 and 24 months. EMC of the bone is a diagnostic dilemma and requires molecular confirmation. We propose to classify tumors with the appropriate phenotype and molecularly confirmed NR4A3/EWSR1 rearrangements as myxochondroid sarcoma, either osseous or extraskeletal variants.

AB - Extraskeletal myxoid chondrosarcoma (EMC) is a rare mesenchymal neoplasm with a characteristic translocation usually involving NR4A3 and EWSR1. EMC has rarely been reported in the bone and may be confused with conventional chondrosarcoma with myxoid features or various small round cell sarcomas. We present 5 cases of molecularly confirmed EMC arising primarily in the bone. Patients included 4 men and 1 woman, aged 38 to 77 years (median 54 y). Tumors arose in the ilium (2 cases), manubrium, rib, and humerus. Four tumors extensively infiltrated and destroyed preexisting bone with cortical breakthrough and associated soft tissue extension; 1 case demonstrated only focal cortical breakthrough. Microscopically, 2 cases had small round cell features; 1 of these was hypercellular, whereas the other was hypocellular with abundant myxochondroid matrix. Three cases were composed of eosinophilic spindled cells with variable fascicular to corded or wreath-like growth patterns. Fluorescence in situ hybridization was positive for both EWSR1 and NR4A3 translocation in 3 cases; rearrangement for EWSR1 or NR4A3, but not both, was seen in 2 tumors. After definitive therapy, 1 patient experienced multiple local recurrences at 36 months and died of disease at 61 months. Two patients developed lung metastases at 26 and 74 months and are alive with disease at 44 and 74 months, respectively. Two patients are disease free at 5 and 24 months. EMC of the bone is a diagnostic dilemma and requires molecular confirmation. We propose to classify tumors with the appropriate phenotype and molecularly confirmed NR4A3/EWSR1 rearrangements as myxochondroid sarcoma, either osseous or extraskeletal variants.

KW - EWSR1

KW - NR4A3

KW - bone

KW - extraskeletal myxoid chondrosarcoma

KW - imaging

KW - molecular diagnostics

KW - myxochondroid sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84876569410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876569410&partnerID=8YFLogxK

U2 - 10.1097/PAS.0b013e3182796e46

DO - 10.1097/PAS.0b013e3182796e46

M3 - Article

VL - 37

SP - 752

EP - 762

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 5

ER -